Full Press Release Details
NASHUA, N.H., Aug. 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, and Stacey Stevens, President, will participate in a fireside chat at the Guggenheim MedTech Disruptors Summit, taking place virtually on August 9-10, 2021.
Fireside Chat Details
Date: August 10, 2021
Time: 10:00am Eastern Time
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Jeremy Feffer, LifeSci Advisors